Progesterone Formulations

Patent No. EP3560500 (titled "Progesterone Formulations") was filed by Therapeuticsmd on Jun 18, 2013. The application was issued on Dec 22, 2021.

Patent Summary

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
DR SCHONSep 22, 2022DR SCHON
RIECKSep 21, 2022FUCHS PATENTANWALTE PARTNERSCHAFT MBB

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3560500

THERAPEUTICSMD
Application Number
EP19163006A
Filing Date
Jun 18, 2013
Status
Revoked
Sep 15, 2023
Publication Date
Dec 22, 2021